Search Results

By Julia E. Maxson, PhD, and Jeffrey W. Tyner, PhD  / June 25, 2013

SIDEBAR: New Insights into Treatment for Two Types of Leukemia 

The combination of functional and genomic screens has allowed us to accelerate the identification of oncogenes, as well as drug sensitivity that corresponds with those oncogenes. In the present study, we found that CSF3R mutations define chronic neutrophilic leukemia and atypical chronic myeloid...